![Pharmaceuticals | Free Full-Text | Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates | HTML Pharmaceuticals | Free Full-Text | Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-01084/article_deploy/html/images/pharmaceuticals-14-01084-g002.png)
Pharmaceuticals | Free Full-Text | Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates | HTML
![Medical Treatment Can Unintentionally Alter the Regulatory T-Cell Compartment in Patients with Widespread Pathophysiologic Conditions - The American Journal of Pathology Medical Treatment Can Unintentionally Alter the Regulatory T-Cell Compartment in Patients with Widespread Pathophysiologic Conditions - The American Journal of Pathology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d4dee775-8333-42f7-98bb-745e264b649e/gr1_lrg.jpg)
Medical Treatment Can Unintentionally Alter the Regulatory T-Cell Compartment in Patients with Widespread Pathophysiologic Conditions - The American Journal of Pathology
![Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution | Pharmacological Reviews Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution | Pharmacological Reviews](https://pharmrev.aspetjournals.org/sites/default/files/highwire/pharmrev/72/2.cover-source.jpg)
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution | Pharmacological Reviews
![Reumatologia – Da poco in commercio anche in Italia penna pre-riempita con certolizumab pegol – I Malati Invisibili Reumatologia – Da poco in commercio anche in Italia penna pre-riempita con certolizumab pegol – I Malati Invisibili](https://www.imalatiinvisibili.it/wp-content/uploads/2017/10/reumatismi_articolari_NG2_15951-300x200.jpg)
Reumatologia – Da poco in commercio anche in Italia penna pre-riempita con certolizumab pegol – I Malati Invisibili
![Hepatic manifestations of inflammatory bowel diseases - Restellini - 2017 - Liver International - Wiley Online Library Hepatic manifestations of inflammatory bowel diseases - Restellini - 2017 - Liver International - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/73ef6489-59cc-4cf3-ae12-78a980a7e347/liv.2017.37.issue-4.cover.jpg)
Hepatic manifestations of inflammatory bowel diseases - Restellini - 2017 - Liver International - Wiley Online Library
![Pharmaceuticals | Free Full-Text | Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates | HTML Pharmaceuticals | Free Full-Text | Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-01084/article_deploy/html/images/pharmaceuticals-14-01084-g001.png)
Pharmaceuticals | Free Full-Text | Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates | HTML
![PDF) Access criteria for anti-TNF agents in spondyloarthritis: Influence on comparative 1-year cost-effectiveness estimates PDF) Access criteria for anti-TNF agents in spondyloarthritis: Influence on comparative 1-year cost-effectiveness estimates](https://i1.rgstatic.net/publication/319626853_Access_criteria_for_anti-TNF_agents_in_spondyloarthritis_Influence_on_comparative_1-year_cost-effectiveness_estimates/links/59b68548aca2722453a3d017/largepreview.png)
PDF) Access criteria for anti-TNF agents in spondyloarthritis: Influence on comparative 1-year cost-effectiveness estimates
![Pharmaceuticals | Free Full-Text | Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates | HTML Pharmaceuticals | Free Full-Text | Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-01084/article_deploy/html/images/pharmaceuticals-14-01084-ag-550.jpg)